Long acting insulin for reducing cardiovascular morbidity...

Details Long acting insulin for reducing cardiovascular morbidity... Long acting insulin for reducing cardiovascular morbidity...

A - Human Necessities

61

K

A61K 38/28 (2006.01) A61P 3/08 (2006.01) A61P 3/10 (2006.01) A61P 9/10 (2006.01)

Patent

CA 2512820

This invention relates to a method of reducing cardiovascular morbidity and mortality in a prediabetic or Type 2 Diabetes patient population. The method comprises administering an effective dosage of a long acting insulin, preferably insulin glargine, to a prediabetic or Type 2 Diabetes patient.

Cette invention concerne une méthode de réduction de la morbidité et de la mortalité cardiovasculaires chez des patients prédiabétiques ou atteints de diabète non insulino-dépendant. La méthode consiste à administrer une dose efficace d'une insuline à action prolongée, de préférence de l'insuline glargine, à un patient prédiabétique ou atteint de diabète non insulino-dépendant.

Affiliated with

Also associated with

Rating

Long acting insulin for reducing cardiovascular morbidity... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Long acting insulin for reducing cardiovascular morbidity..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Long acting insulin for reducing cardiovascular morbidity... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1622061